新陈代谢
生物
糖酵解
血管生成
细胞代谢
谷氨酰胺
碳水化合物代谢
代谢性疾病
疾病
细胞生物学
脂肪酸代谢
内皮
代谢途径
肿瘤微环境
内皮干细胞
癌细胞
癌症
癌症研究
生物化学
肿瘤细胞
内分泌学
内科学
氨基酸
医学
遗传学
体外
作者
Kateřina Rohlenová,Koen Veys,Ines Miranda Santos,Katrien De Bock,Peter Carmeliet
标识
DOI:10.1016/j.tcb.2017.10.010
摘要
The metabolism of endothelial cells (ECs) has only recently been recognized as a driving force of angiogenesis. Metabolic pathways, such as glycolysis, fatty acid oxidation, and glutamine metabolism, have distinct, essential roles during vessel formation. Moreover, EC metabolism is markedly perturbed in pathologies such as cancer and diabetes. For instance, because tumor ECs increase glycolysis, lowering hyperglycolysis in tumor ECs induces therapeutic benefits in preclinical tumor models. Expanding our knowledge of how ECs alter their metabolism in disease could pave the way for novel therapeutic opportunities. In this review, we discuss the most recent insights into EC metabolism in health and disease, with emphasis on the changes in metabolism in the tumor endothelium.
科研通智能强力驱动
Strongly Powered by AbleSci AI